Regulation of p53 protein expression in human breast cancer cell linesVOJTESEK, B; LANE, D. P.Journal of Cell Science. 1993, Vol 105, pp 607-612, issn 0021-9533, 3Article

Diversity of human p53 mutants revelaed by complex formation to SV40 T antigenBARTEK, J; VOJTESEK, B; LANE, D. P et al.European journal of cancer. Part A. 1993, Vol 29, Num 1, pp 101-107Article

The p53 knowledgebase : an integrated information resource for p53 researchLIM, Y. P; LIM, T. T; CHAN, Y. L et al.Oncogene (Basingstoke). 2007, Vol 26, Num 11, pp 1517-1521, issn 0950-9232, 5 p.Article

Comparison between p53 staining in tissue sections and p53 proteins levels measured by an ELISA techniqueVOJTESEK, B; FISHER, C. J; BARNES, D. M et al.British journal of cancer. 1993, Vol 67, Num 6, pp 1254-1258, issn 0007-0920Article

p53 Protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasiaBARTKOVA, J; BARTEK, J; VOJTESEK, B et al.International journal of cancer. 1991, Vol 49, Num 2, pp 196-202, issn 0020-7136Article

HPV-16 E7 or adenovirus E1A can overcome the growth arrest of cells immortalized with a temperature-sensitive p53VOUSDEN, K. H; VOJTESEK, B; FISHER, C et al.Oncogene (Basingstoke). 1993, Vol 8, Num 6, pp 1697-1702, issn 0950-9232Article

Asymmetric PCR-based strategy for genetic analysis of the p53 tumor suppressor gene in cell lines and tumor tissuesBARTEK, J; IGGO, R; VOJTESEK, B et al.Neoplasma. 1991, Vol 38, Num 1, pp 93-99, issn 0028-2685Article

Novel monoclonal antibodies defining epitope of human cytokeratin 18 moleculeLAUEROVA, L; KOVARIK, J; BARTEK, J et al.Hybridoma. 1988, Vol 7, Num 5, pp 495-504, issn 0272-457XArticle

Detection of the p53 response in zebrafish embryos using new monoclonal antibodiesLEE, K.-C; GOH, W. L. P; XU, M et al.Oncogene (Basingstoke). 2008, Vol 27, Num 5, pp 629-640, issn 0950-9232, 12 p.Article

Differential expression of p73α in normal ectocervical epithelium, cervical intraepithelial neoplasia, and invasive squamous cell carcinomaNENUTIL, R; CESKOVA, P; COATES, P. J et al.International journal of gynecological pathology. 2003, Vol 22, Num 4, pp 386-392, issn 0277-1691, 7 p.Article

Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodiesBARTEK, J; BARTKOVA, J; LUKAS, J et al.Journal of pathology. 1993, Vol 169, Num 1, pp 27-34, issn 0022-3417Article

Abnormal expression of wild type p53 protein in normal cells of a cancer family patientBARNES, D. M; HANBY, A. M; BARTEK, J et al.Lancet (British edition). 1992, Vol 340, Num 8814, pp 259-263, issn 0140-6736Article

Analysis of p53 expression in human tumours : an antibody raised against human p53 expressed in Escherichia coliMIDGLEY, C. A; FISHER, C. J; BARTEK, J et al.Journal of Cell Science. 1992, Vol 101, pp 183-189, issn 0021-9533, 8 p., 1Article

An imunochemical analysis of the human nuclear phosphoprotein p53 : new monoclonal antibodies and epitope mapping using recombinant p53VOJTESEK, B; BARTEK, J; MIDGLEY, C. A et al.Journal of immunological methods. 1992, Vol 151, Num 1-2, pp 237-244, issn 0022-1759Article

Identification of αΒ-crystallin, a biomarker of renal cell carcinoma by SELDI-TOF MSHOLCAKOVA, J; HERNYCHOVA, L; BOUCHAL, P et al.The International journal of biological markers. 2008, Vol 23, Num 1, pp 48-53, issn 0393-6155, 6 p.Article

Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell linesMAD'AROVA, J; LUKESOVA, M; HLOBILKOVA, A et al.MP. Molecular pathology. 2002, Vol 55, Num 4, pp 227-234, issn 1366-8714Article

Cellular localization and T antigen binding of the retinoblastoma proteinBARTEK, J; VOJTESEK, B; GRAND, R. J. A et al.Oncogene (Basingstoke). 1992, Vol 7, Num 1, pp 101-108, issn 0950-9232Article

Differential expression of keratin 19 in normal human epithelial tissues revealed by monospecific monoclonal antibodiesBARTEK, J; BARTKOVA, J; TAYLOR-PAPADIMITRIOU, J et al.Histochemical journal. 1986, Vol 18, Num 10, pp 565-575, issn 0018-2214Article

Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiationCANDEIAS, M. M; POWELL, D. J; ROUBALOVA, E et al.Oncogene (Basingstoke). 2006, Vol 25, Num 52, pp 6936-6947, issn 0950-9232, 12 p.Article

Apoptosis-related proteins, BCL-2, BAX, FAS, FAS-L and PCNA in liver biopsies of patients with chronic hepatitis B virus infectionEHRMANN, Jiri JR; GALUSZKOVA, D; EHRMANN, Jiri et al.Pathology oncology research. 2000, Vol 6, Num 2, pp 130-135, issn 1219-4956Article

Up-regulation of FAS (CD95) in human p53^WILD-TYPE cancer cells treated with ionizing radiationSHEARD, M. A; VOJTESEK, B; JANAKOVA, L et al.International journal of cancer. 1997, Vol 73, Num 5, pp 757-762, issn 0020-7136Article

A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignanciesSPEISER, P; GHAREHBAGHI-SCHNELL, E; ZEILLINGER, R et al.British journal of cancer. 1996, Vol 74, Num 2, pp 269-273, issn 0007-0920Article

Enzyme-linked immunosorbent for p53 in gastrointestinal malignancy : comparison with immunohistochemistryJOYPAUL, B. V; VOJTESEK, B; NEWMAN, E. L et al.Histopathology. 1993, Vol 23, Num 5, pp 465-470, issn 0309-0167Article

Subtypes of non-transformed human mammary epithelial cells cultured in vitro : histo-blood group antigen H type 2 defines basal cell-derived cellsKARSTEN, U; PAPSDORF, G; PAULY, A et al.Differentiation (London). 1993, Vol 54, Num 1, pp 55-66, issn 0301-4681Article

Effects of tissue fixation conditions and protease pretreatment on immunohistochemical performance of a large series of new anti-keratin monoclonal antibodies : value in oncopathologyBARTKOVA, J; BARTEK, J; LUKAS, Z et al.Neoplasma. 1991, Vol 38, Num 4, pp 439-446, issn 0028-2685Article